Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 17 studies | 29% ± 12% | |
peripheral blood | 17 studies | 37% ± 12% | |
intestine | 8 studies | 24% ± 6% | |
brain | 7 studies | 25% ± 4% | |
lymph node | 6 studies | 25% ± 10% | |
liver | 6 studies | 33% ± 14% | |
kidney | 5 studies | 23% ± 4% | |
uterus | 5 studies | 41% ± 12% | |
pancreas | 4 studies | 38% ± 16% | |
placenta | 4 studies | 25% ± 11% | |
bone marrow | 4 studies | 30% ± 10% | |
breast | 4 studies | 41% ± 16% | |
eye | 3 studies | 25% ± 7% | |
esophagus | 3 studies | 29% ± 10% | |
prostate | 3 studies | 51% ± 5% | |
adipose | 3 studies | 27% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 5121.76 | 1442 / 1445 | 100% | 150.77 | 183 / 183 |
lung | 100% | 7440.82 | 576 / 578 | 100% | 98.86 | 1152 / 1155 |
ovary | 99% | 4517.64 | 179 / 180 | 100% | 69.52 | 429 / 430 |
intestine | 100% | 4313.22 | 963 / 966 | 99% | 118.43 | 524 / 527 |
stomach | 100% | 4335.19 | 358 / 359 | 99% | 113.23 | 284 / 286 |
breast | 100% | 7530.99 | 459 / 459 | 99% | 95.49 | 1104 / 1118 |
pancreas | 99% | 4379.93 | 326 / 328 | 98% | 68.11 | 175 / 178 |
bladder | 100% | 5038.00 | 21 / 21 | 97% | 85.13 | 491 / 504 |
uterus | 100% | 4535.58 | 170 / 170 | 97% | 76.72 | 444 / 459 |
prostate | 98% | 3698.28 | 239 / 245 | 96% | 62.37 | 480 / 502 |
thymus | 100% | 4325.19 | 651 / 653 | 93% | 39.81 | 560 / 605 |
skin | 100% | 9408.43 | 1808 / 1809 | 92% | 77.74 | 432 / 472 |
kidney | 99% | 3284.78 | 88 / 89 | 87% | 45.81 | 786 / 901 |
adrenal gland | 100% | 4506.91 | 258 / 258 | 85% | 35.49 | 196 / 230 |
brain | 71% | 1271.19 | 1887 / 2642 | 97% | 42.12 | 685 / 705 |
liver | 88% | 3213.66 | 199 / 226 | 79% | 31.61 | 320 / 406 |
adipose | 100% | 9677.11 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 4478.22 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 24.07 | 1 / 1 |
blood vessel | 100% | 5244.40 | 1332 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 6425.37 | 801 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 87.62 | 44 / 45 |
lymph node | 0% | 0 | 0 / 0 | 93% | 96.07 | 27 / 29 |
heart | 90% | 3077.94 | 771 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 77% | 5334.53 | 717 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 70% | 28.53 | 56 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006366 | Biological process | transcription by RNA polymerase II |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0016479 | Biological process | negative regulation of transcription by RNA polymerase I |
GO_0045087 | Biological process | innate immune response |
GO_0001649 | Biological process | osteoblast differentiation |
GO_0002735 | Biological process | positive regulation of myeloid dendritic cell cytokine production |
GO_0043330 | Biological process | response to exogenous dsRNA |
GO_0051607 | Biological process | defense response to virus |
GO_0006338 | Biological process | chromatin remodeling |
GO_0045945 | Biological process | positive regulation of transcription by RNA polymerase III |
GO_0043123 | Biological process | positive regulation of canonical NF-kappaB signal transduction |
GO_0045943 | Biological process | positive regulation of transcription by RNA polymerase I |
GO_0062176 | Biological process | R-loop processing |
GO_0006364 | Biological process | rRNA processing |
GO_0005730 | Cellular component | nucleolus |
GO_0110016 | Cellular component | B-WICH complex |
GO_0016020 | Cellular component | membrane |
GO_0005739 | Cellular component | mitochondrion |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005694 | Cellular component | chromosome |
GO_0019843 | Molecular function | rRNA binding |
GO_0003724 | Molecular function | RNA helicase activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0003729 | Molecular function | mRNA binding |
GO_0030515 | Molecular function | snoRNA binding |
GO_0097322 | Molecular function | 7SK snRNA binding |
GO_0140870 | Molecular function | RNA polymerase inhibitor activity |
GO_0005524 | Molecular function | ATP binding |
GO_0003723 | Molecular function | RNA binding |
GO_0035198 | Molecular function | miRNA binding |
GO_0005515 | Molecular function | protein binding |
GO_0016887 | Molecular function | ATP hydrolysis activity |
GO_0003725 | Molecular function | double-stranded RNA binding |
Gene name | DDX21 |
Protein name | RNA helicase (EC 3.6.4.13) DDX21 protein Nucleolar RNA helicase 2 (EC 3.6.4.13) (DEAD box protein 21) (Gu-alpha) (Nucleolar RNA helicase Gu) (Nucleolar RNA helicase II) (RH II/Gu) |
Synonyms | |
Description | FUNCTION: RNA helicase that acts as a sensor of the transcriptional status of both RNA polymerase (Pol) I and II: promotes ribosomal RNA (rRNA) processing and transcription from polymerase II (Pol II) . Binds various RNAs, such as rRNAs, snoRNAs, 7SK and, at lower extent, mRNAs . In the nucleolus, localizes to rDNA locus, where it directly binds rRNAs and snoRNAs, and promotes rRNA transcription, processing and modification. Required for rRNA 2'-O-methylation, possibly by promoting the recruitment of late-acting snoRNAs SNORD56 and SNORD58 with pre-ribosomal complexes . In the nucleoplasm, binds 7SK RNA and is recruited to the promoters of Pol II-transcribed genes: acts by facilitating the release of P-TEFb from inhibitory 7SK snRNP in a manner that is dependent on its helicase activity, thereby promoting transcription of its target genes . Functions as a cofactor for JUN-activated transcription: required for phosphorylation of JUN at 'Ser-77' . Can unwind double-stranded RNA (helicase) and can fold or introduce a secondary structure to a single-stranded RNA (foldase) . Together with SIRT7, required to prevent R-loop-associated DNA damage and transcription-associated genomic instability: deacetylation by SIRT7 activates the helicase activity, thereby overcoming R-loop-mediated stalling of RNA polymerases . Involved in rRNA processing . May bind to specific miRNA hairpins . Component of a multi-helicase-TICAM1 complex that acts as a cytoplasmic sensor of viral double-stranded RNA (dsRNA) and plays a role in the activation of a cascade of antiviral responses including the induction of pro-inflammatory cytokines via the adapter molecule TICAM1 (By similarity). . |
Accessions | ENST00000354185.9 [Q9NR30-1] Q3SWU7 ENST00000690316.1 [Q9NR30-2] A0A8I5KYZ4 Q9NR30 ENST00000690650.1 A0A8I5KND9 A0A8I5KNN2 ENST00000684824.1 ENST00000685106.1 ENST00000686528.1 A0A8I5KNP3 ENST00000620315.2 [Q9NR30-2] |